Pharmacokinetics and dosage regimen of levofl oxacin in buffalo Pharmacokinetics and dosage regimen of levofl oxacin in buffalo calves after single subcutaneous administration calves after single subcutaneous administration

The present study was conducted on six male buffalo calves to investigate the pharmacokinetics of The present study was conducted on six male buffalo calves to investigate the pharmacokinetics of levofl oxacin following a single subcutaneous administration at the dose rate of 3 mg.kg levofl oxacin following a single subcutaneous administration at the dose rate of 3 mg.kg-1 -1 body weight. body weight. Appreciable plasma concentration of levofl oxacin (0.28 ± 0.01 Appreciable plasma concentration of levofl oxacin (0.28 ± 0.01 μg.mL g.mL -1 -1 ) was detected 2.5 min after injection ) was detected 2.5 min after injection

[1]  A. Srivastava,et al.  Kinetic disposition, urinary excretion and dosage regimen of subcutaneously administered levofloxacin in cross bred calves , 2007 .

[2]  V. Dumka.  Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves , 2007, Journal of veterinary science.

[3]  A. Duggirala,et al.  Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison. , 2007, Indian journal of ophthalmology.

[4]  H. Sandhu,et al.  Gatifloxacin pharmacokinetics in buffalo calves after single intramuscular administration , 2006 .

[5]  J. Bakken.  The fluoroquinolones: How long will their utility last? , 2004, Scandinavian journal of infectious diseases.

[6]  Aziza,et al.  Some Pharmacokinetic Data for Danofloxacin in Healthy Goats , 2001, Veterinary Research Communications.

[7]  M. Schneider,et al.  Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. , 2004, Journal of dairy science.

[8]  L. Drago,et al.  Activity of levofloxacin and ciprofloxacin against urinary pathogens. , 2001, The Journal of antimicrobial chemotherapy.

[9]  H. Lamb,et al.  Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. , 1998, Drugs.

[10]  A. Glickman,et al.  Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. , 1997, Zentralblatt fur Veterinarmedizin. Reihe A.

[11]  P. Edelstein,et al.  In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. , 1996, The Journal of antimicrobial chemotherapy.

[12]  G. Riess,et al.  Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. , 1995, The Journal of antimicrobial chemotherapy.

[13]  D. Upson,et al.  Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia. , 1993, American journal of veterinary research.

[14]  J. Baggot.  Principles of drug disposition in domestic animals the basis of veterinary clinical pharmacology , 1977 .

[15]  D. P. Johnson,et al.  Outline of details for microbiological assays of antibiotics: second revision. , 1971, Journal of pharmaceutical sciences.